crc press - E-Lib FK UWKS

Microbial Membrane-Permeating Peptides and Their Applications 395
50. Lehrer, R.I. and Ganz, T., Antimicrobial peptides in mammalian and insect host
defence, Curr. Opin. Immunol., 11, 23, 1999.
51. DeLucca, A.J. et al., Fungicidal activity of cecropin A, Antimicrob. Agents
Chemother., 41, 481, 1997.
52. Hultmark, D. et al., Insect immunity. Attacins, a family of antibacterial proteins from
Hyalophora cecropia, Embo J., 2, 571, 1983.
53. Wu, M. and Hancock, R.E., Interaction of the cyclic antimicrobial cationic peptide
bactenecin with the outer and cytoplasmic membrane, J. Biol. Chem., 274, 29, 1999.
54. Lorian, V., Antibiotics in Laboratory Medicine, 4th ed., Williams & Wilkins, Baltimore,
1996.
55. Mason, D.J. et al., Antimicrobial action of rabbit leukocyte CAP18(106-137), Antimicrob.
Agents Chemother., 41, 624, 1997.
56. Lehrer, R.I., Barton, A., and Ganz, T., Concurrent assessment of inner and outer
membrane permeabilization and bacteriolysis in E. coli by multiple-wavelength spectrophotometry,
J. Immunol. Methods, 108, 153, 1988.
57. Giacometti, A. et al., In-vitro activity and killing effect of polycationic peptides on
methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics,
Diagn. Microbiol. Infect. Dis., 38, 115, 2000.
58. Linde, C.M. et al., In vitro activity of PR-39, a proline-arginine-rich peptide, against
susceptible and multi-drug-resistant Mycobacterium tuberculosis, J. Antimicrob.
Chemother., 47, 575, 2001.
59. Steinberg, D.A. et al., Protegrin-1: a broad-spectrum, rapidly microbicidal peptide
with in vivo activity, Antimicrob. Agents Chemother., 41, 1738, 1997.
60. Ahmad, I. et al., Liposomal entrapment of the neutrophil-derived peptide indolicidin
endows it with in vivo antifungal activity, Biochim. Biophys. Acta, 1237, 109, 1995.
61. Welling, M.M. et al., Antibacterial activity of human neutrophil defensins in experimental
infections in mice is accompanied by increased leukocyte accumulation,
J. Clin. Invest., 102, 1583, 1998.
62. Bals, R. et al., Augmentation of innate host defense by expression of a cathelicidin
antimicrobial peptide, Infect. Immun., 67, 6084, 1999.
63. Kisich, K.O. et al., Antimycobacterial agent based on mRNA encoding human betadefensin
2 enables primary macrophages to restrict growth of Mycobacterium tuberculosis,
Infect. Immun., 69, 2692, 2001.
64. Tsiodras, S. et al., Linezolid resistance in a clinical isolate of Staphylococcus aureus,
Lancet, 358, 207, 2001.
65. Gonzales, R.D. et al., Infections due to vancomycin-resistant Enterococcus faecium
resistant to linezolid, Lancet, 357, 1179, 2001.
66. Hancock, R.E., The bacterial outer membrane as a drug barrier, Trends Microbiol.,
5, 37, 1997.
67. Wittung, P. et al., Phospholipid membrane permeability of peptide nucleic acid, FEBS
Lett., 365, 27, 1995.
68. Good, L. and Nielsen, P.E., Inhibition of translation and bacterial growth by peptide
nucleic acid targeted to ribosomal RNA, Proc. Natl. Acad. Sci. U.S.A., 95, 2073, 1998.
69. Good, L. et al., Antisense PNA effects in Escherichia coli are limited by the outermembrane
LPS layer, Microbiology, 146, 2665, 2000.
70. Vaara, M. and Porro, M., Group of peptides that act synergistically with hydrophobic
antibiotics against gram-negative enteric bacteria, Antimicrob. Agents Chemother., 40,
1801, 1996.
71. Cronan, J.E. and Rock, C.O., Escherichia coli and Salmlonella: Cellular and Molecular
Biology, 2nd ed., American Society for Microbiology, Washington, D.C., 1996.